Submission Details
| 510(k) Number | K991362 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 14, 1999 |
| Decision Date | June 21, 1999 |
| Days to Decision | 68 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Statement |
K991362 is an FDA 510(k) clearance for the HYDRAGEL HEMOGLOBIN(E), MINI HEMOGLOBIN(E), 7 HEMOGLOBIN(E), 15 HEMOGLOBIN(E), ACID(E) HEMOGLOBIN(E), MINI ACID(E) HEMO), a System, Analysis, Electrophoretic Hemoglobin (Class II — Special Controls, product code JBD), submitted by Morax (Chelsea, US). The FDA issued a Cleared decision on June 21, 1999, 68 days after receiving the submission on April 14, 1999. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7440.
| 510(k) Number | K991362 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 14, 1999 |
| Decision Date | June 21, 1999 |
| Days to Decision | 68 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Statement |
| Product Code | JBD — System, Analysis, Electrophoretic Hemoglobin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7440 |